Concepts (155)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Seizures | 19 | 2024 | 314 | 3.590 |
Why?
|
| Electroencephalography | 25 | 2025 | 772 | 3.570 |
Why?
|
| Status Epilepticus | 8 | 2025 | 41 | 3.140 |
Why?
|
| Anticonvulsants | 10 | 2024 | 127 | 2.720 |
Why?
|
| Epilepsy | 10 | 2024 | 431 | 1.620 |
Why?
|
| Critical Illness | 4 | 2023 | 327 | 0.930 |
Why?
|
| Brain Diseases | 1 | 2025 | 186 | 0.840 |
Why?
|
| Triazines | 3 | 2011 | 55 | 0.680 |
Why?
|
| Brain | 6 | 2025 | 2355 | 0.680 |
Why?
|
| Neurophysiology | 3 | 2013 | 14 | 0.600 |
Why?
|
| Benzodiazepines | 3 | 2024 | 68 | 0.590 |
Why?
|
| Multicenter Studies as Topic | 3 | 2013 | 172 | 0.580 |
Why?
|
| Brain Injuries | 3 | 2021 | 169 | 0.560 |
Why?
|
| Drug Resistant Epilepsy | 4 | 2025 | 57 | 0.550 |
Why?
|
| Monitoring, Physiologic | 7 | 2023 | 268 | 0.550 |
Why?
|
| Terminology as Topic | 3 | 2020 | 224 | 0.480 |
Why?
|
| Nervous System Diseases | 2 | 2006 | 159 | 0.460 |
Why?
|
| Humans | 44 | 2025 | 92331 | 0.400 |
Why?
|
| Brain Waves | 3 | 2018 | 32 | 0.400 |
Why?
|
| Piracetam | 2 | 2010 | 8 | 0.360 |
Why?
|
| Electrodes, Implanted | 2 | 2024 | 197 | 0.340 |
Why?
|
| Fructose | 2 | 2010 | 36 | 0.330 |
Why?
|
| Drug Resistance | 1 | 2010 | 235 | 0.310 |
Why?
|
| Middle Aged | 21 | 2025 | 27043 | 0.300 |
Why?
|
| Neuroprotective Agents | 2 | 2006 | 95 | 0.300 |
Why?
|
| Cognition Disorders | 1 | 2008 | 240 | 0.260 |
Why?
|
| Male | 24 | 2025 | 43922 | 0.250 |
Why?
|
| Aged | 15 | 2025 | 19951 | 0.250 |
Why?
|
| Electrocorticography | 2 | 2024 | 47 | 0.250 |
Why?
|
| Female | 24 | 2025 | 47895 | 0.240 |
Why?
|
| Adult | 16 | 2025 | 27540 | 0.240 |
Why?
|
| Cerebral Cortex | 1 | 2009 | 593 | 0.240 |
Why?
|
| Retrospective Studies | 10 | 2024 | 9693 | 0.240 |
Why?
|
| Emergency Medical Services | 1 | 2008 | 253 | 0.230 |
Why?
|
| Theta Rhythm | 1 | 2025 | 36 | 0.230 |
Why?
|
| Acute Disease | 2 | 2024 | 855 | 0.230 |
Why?
|
| Evidence-Based Practice | 1 | 2024 | 49 | 0.220 |
Why?
|
| Subdural Space | 1 | 2024 | 19 | 0.220 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2010 | 1938 | 0.220 |
Why?
|
| Diet, Ketogenic | 1 | 2024 | 13 | 0.220 |
Why?
|
| Intensive Care Units | 4 | 2020 | 429 | 0.210 |
Why?
|
| Young Adult | 8 | 2025 | 6629 | 0.210 |
Why?
|
| Fever | 1 | 2024 | 130 | 0.200 |
Why?
|
| Mental Disorders | 1 | 2006 | 424 | 0.200 |
Why?
|
| Adolescent | 8 | 2024 | 9495 | 0.190 |
Why?
|
| Hippocampus | 1 | 2025 | 435 | 0.180 |
Why?
|
| Cytokines | 1 | 2025 | 842 | 0.180 |
Why?
|
| Nerve Net | 1 | 2025 | 396 | 0.180 |
Why?
|
| Posterior Leukoencephalopathy Syndrome | 1 | 2021 | 13 | 0.180 |
Why?
|
| Aged, 80 and over | 5 | 2019 | 6917 | 0.160 |
Why?
|
| Periodicity | 2 | 2018 | 119 | 0.160 |
Why?
|
| Machine Learning | 2 | 2019 | 299 | 0.160 |
Why?
|
| Inflammation | 1 | 2025 | 1024 | 0.150 |
Why?
|
| Immunotherapy | 1 | 2024 | 725 | 0.150 |
Why?
|
| Myelitis, Transverse | 1 | 2007 | 10 | 0.140 |
Why?
|
| Patient Discharge | 1 | 2020 | 339 | 0.130 |
Why?
|
| Inpatients | 1 | 2020 | 331 | 0.130 |
Why?
|
| Tuberculosis, Spinal | 1 | 2006 | 1 | 0.130 |
Why?
|
| Myelitis | 1 | 2006 | 2 | 0.130 |
Why?
|
| Tuberculosis, Meningeal | 1 | 2006 | 2 | 0.130 |
Why?
|
| Length of Stay | 1 | 2020 | 790 | 0.130 |
Why?
|
| Brain Injuries, Traumatic | 1 | 2018 | 107 | 0.120 |
Why?
|
| Patient Readmission | 1 | 2020 | 391 | 0.120 |
Why?
|
| Risk Factors | 3 | 2020 | 5708 | 0.120 |
Why?
|
| Drug Therapy, Combination | 2 | 2008 | 806 | 0.120 |
Why?
|
| Laughter | 1 | 2005 | 4 | 0.120 |
Why?
|
| Brain Stem Infarctions | 1 | 2005 | 5 | 0.120 |
Why?
|
| Pons | 1 | 2005 | 26 | 0.120 |
Why?
|
| Basilar Artery | 1 | 2005 | 40 | 0.120 |
Why?
|
| Patient Compliance | 1 | 2007 | 236 | 0.120 |
Why?
|
| Affective Symptoms | 1 | 2005 | 52 | 0.120 |
Why?
|
| Delta Rhythm | 2 | 2017 | 19 | 0.120 |
Why?
|
| Age Factors | 2 | 2011 | 1904 | 0.110 |
Why?
|
| Brain Mapping | 2 | 2024 | 580 | 0.110 |
Why?
|
| Myocardial Infarction | 1 | 2007 | 402 | 0.100 |
Why?
|
| Intracranial Aneurysm | 1 | 2005 | 200 | 0.100 |
Why?
|
| Reproducibility of Results | 4 | 2023 | 2793 | 0.100 |
Why?
|
| Treatment Outcome | 4 | 2025 | 8730 | 0.100 |
Why?
|
| Child | 4 | 2024 | 7309 | 0.100 |
Why?
|
| Predictive Value of Tests | 2 | 2024 | 1761 | 0.090 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2024 | 3514 | 0.090 |
Why?
|
| Tremor | 1 | 2011 | 23 | 0.090 |
Why?
|
| Sleep Stages | 1 | 2011 | 47 | 0.090 |
Why?
|
| Postural Balance | 1 | 2011 | 50 | 0.090 |
Why?
|
| Drug Interactions | 1 | 2011 | 245 | 0.090 |
Why?
|
| Prognosis | 3 | 2018 | 3871 | 0.090 |
Why?
|
| Cyclohexanecarboxylic Acids | 1 | 2010 | 18 | 0.080 |
Why?
|
| Phenytoin | 1 | 2010 | 15 | 0.080 |
Why?
|
| Amines | 1 | 2010 | 30 | 0.080 |
Why?
|
| Carbamazepine | 1 | 2010 | 10 | 0.080 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2010 | 85 | 0.080 |
Why?
|
| Postoperative Complications | 1 | 2020 | 2453 | 0.080 |
Why?
|
| Barbiturates | 1 | 2008 | 12 | 0.070 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2009 | 203 | 0.070 |
Why?
|
| Injections, Intravenous | 1 | 2008 | 238 | 0.070 |
Why?
|
| Outpatients | 1 | 2008 | 106 | 0.070 |
Why?
|
| Propofol | 1 | 2008 | 92 | 0.070 |
Why?
|
| Stroke | 1 | 2007 | 1038 | 0.070 |
Why?
|
| Metabolic Clearance Rate | 1 | 2007 | 118 | 0.070 |
Why?
|
| Enzyme Induction | 1 | 2007 | 87 | 0.070 |
Why?
|
| Hypnotics and Sedatives | 1 | 2008 | 136 | 0.070 |
Why?
|
| Child, Preschool | 2 | 2024 | 3806 | 0.070 |
Why?
|
| Antimanic Agents | 1 | 2006 | 13 | 0.070 |
Why?
|
| Odds Ratio | 1 | 2008 | 694 | 0.070 |
Why?
|
| Expert Testimony | 1 | 2006 | 34 | 0.060 |
Why?
|
| Drug Tolerance | 1 | 2006 | 64 | 0.060 |
Why?
|
| Ambulatory Care | 1 | 2007 | 196 | 0.060 |
Why?
|
| Practice Guidelines as Topic | 2 | 2017 | 1072 | 0.060 |
Why?
|
| Logistic Models | 1 | 2008 | 1239 | 0.060 |
Why?
|
| Critical Care | 2 | 2019 | 397 | 0.060 |
Why?
|
| Epileptic Syndromes | 1 | 2024 | 8 | 0.050 |
Why?
|
| Seizures, Febrile | 1 | 2024 | 25 | 0.050 |
Why?
|
| Electric Stimulation | 1 | 2025 | 371 | 0.050 |
Why?
|
| Temporal Lobe | 1 | 2025 | 185 | 0.050 |
Why?
|
| Electrodes | 1 | 2024 | 89 | 0.050 |
Why?
|
| Neocortex | 1 | 2025 | 103 | 0.050 |
Why?
|
| Stereotaxic Techniques | 1 | 2024 | 82 | 0.050 |
Why?
|
| Rituximab | 1 | 2024 | 123 | 0.050 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2006 | 205 | 0.050 |
Why?
|
| Case-Control Studies | 2 | 2018 | 1900 | 0.050 |
Why?
|
| Algorithms | 2 | 2025 | 1960 | 0.050 |
Why?
|
| Sensitivity and Specificity | 2 | 2017 | 2009 | 0.050 |
Why?
|
| Disease Management | 1 | 2024 | 341 | 0.050 |
Why?
|
| Risk Assessment | 2 | 2020 | 2368 | 0.040 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2006 | 617 | 0.040 |
Why?
|
| Cohort Studies | 2 | 2019 | 2979 | 0.040 |
Why?
|
| Neuronal Plasticity | 1 | 2023 | 195 | 0.040 |
Why?
|
| Clinical Trials as Topic | 1 | 2006 | 1150 | 0.040 |
Why?
|
| Homeostasis | 1 | 2023 | 452 | 0.040 |
Why?
|
| Hospital Mortality | 1 | 2023 | 445 | 0.040 |
Why?
|
| Reference Standards | 1 | 2020 | 143 | 0.040 |
Why?
|
| Cluster Analysis | 1 | 2020 | 376 | 0.040 |
Why?
|
| Time Factors | 2 | 2020 | 5430 | 0.040 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2024 | 976 | 0.040 |
Why?
|
| Pakistan | 1 | 2007 | 15 | 0.030 |
Why?
|
| Hospitals, University | 1 | 2007 | 197 | 0.030 |
Why?
|
| Quality of Life | 1 | 2025 | 1745 | 0.030 |
Why?
|
| False Positive Reactions | 1 | 2016 | 220 | 0.030 |
Why?
|
| Statistics, Nonparametric | 1 | 2016 | 305 | 0.030 |
Why?
|
| Pyramidal Tracts | 1 | 2005 | 19 | 0.030 |
Why?
|
| Vagus Nerve | 1 | 2005 | 49 | 0.030 |
Why?
|
| Aneurysm, False | 1 | 2005 | 54 | 0.030 |
Why?
|
| Deglutition | 1 | 2005 | 79 | 0.030 |
Why?
|
| Respiratory Center | 1 | 2005 | 55 | 0.030 |
Why?
|
| Amygdala | 1 | 2005 | 87 | 0.030 |
Why?
|
| Motivation | 1 | 2007 | 309 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2016 | 1117 | 0.020 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2005 | 351 | 0.020 |
Why?
|
| Anticoagulants | 1 | 2005 | 448 | 0.020 |
Why?
|
| Hospitalization | 1 | 2017 | 925 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2007 | 1773 | 0.020 |
Why?
|
| Research | 1 | 2012 | 254 | 0.020 |
Why?
|
| Observer Variation | 1 | 2012 | 612 | 0.020 |
Why?
|
| Atrial Fibrillation | 1 | 2005 | 378 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2017 | 4474 | 0.020 |
Why?
|